Rank #1779ZNTL

Zentalis Pharmaceuticals, Inc.

$2.52

5.00% (Daily)

Market Cap

$163.17M

Revenue

$26.86M

Rank by MCap

#1779

Sector

Healthcare

Industry

Biotechnology

CEO

Ms. Julie M. Eastland M.B.A.

Headquarters

San Diego, CA

Employees

166

About Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosert...